Yanlian Yang

发表

Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy

Zefei Jiang, Hao Wang, Fei Jia, 2022, Frontiers in Oncology.

OP0216 The Functional Rather than Nonfunctional LILRA3 Contributes to Susceptibility and Subphenotypes of Systemic Lupus Erythematosus and SjÖGren's Syndrome

X. Zuo, Xuejun Zhang, Yong Cui, 2014 .

Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients.

B. Shao, Huiping Li, G. Song, 2017, Breast.

HER2 Phenotyping of CTCs By Peptide-Functionalized Nanoparticles As The Diagnostic Biomarkers of Anti-HER2 Treatment in Breast Cancer

B. Shao, Huiping Li, Ping Li, 2021 .

Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer.

Zhiyuan Hu, H. Rugo, B. Shao, 2018, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Cancer Patients Receiving PD-1/PD-L1 Blockade Therapies.

Zhiyuan Hu, Jianming Xu, Ping Li, 2021, The oncologist.

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment

B. Shao, Huiping Li, Ling Zhu, 2022, Frontiers in Bioengineering and Biotechnology.

Impact of changing treatment strategy based on circulating tumor cells on postoperative survival of breast cancer

Zhongtao Zhang, Wei Xu, Yaqian Xu, 2022, Frontiers in Oncology.

Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies

R. Jia, Chuan-hua Zhao, Rongrui Liu, 2021 .

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation

Yang Song, N. Liang, Yang Song, 2023, Frontiers in Bioengineering and Biotechnology.

Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy

Zhiyuan Hu, Jianming Xu, Ping Li, 2018, Oncoimmunology.

An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer

Shaohua Zhang, Tao Wang, Zefei Jiang, 2022, Frontiers in Oncology.

Clinical outcomes with first-line chemotherapy versus endocrine therapy for adjuvant endocrine therapy-resistant metastatic breast cancer

B. Shao, Huiping Li, Jinrong Qu, 2018, Translational Cancer Research.

Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy

Tao Wang, Zefei Jiang, Jinmei Zhou, 2023, Breast Cancer Research and Treatment.

HER2 Expression in Circulating Tumor Cells as Prognostic and Predictive Biomarkers for Anti‐HER2 Therapy in Previously Treated Metastatic Colorectal Cancer

Ping Li, Jian Li, Xicheng Wang, 2023, Advanced Therapeutics.